Banat 2010
Banat 2010
Banat 2010
DOI 10.1007/s00253-010-2589-0
MINI-REVIEW
Received: 14 February 2010 / Revised: 24 March 2010 / Accepted: 24 March 2010 / Published online: 28 April 2010
# Springer-Verlag 2010
Monorhamnolipids Dirhamnolipid
Trehalose monomycolates
Trehalose dimycolates
Surfactin
Mannosylerythritol lipids
CH3
(CH2)8
CHOH
CH3
CH2
(CH2)9
C O
CHOH O
O
C O O O
C CH2
O
HO O O
CH2 O O
O
O
NH HO NH
C O C O
HO NH n
(CH ) CH3
2 12
C O
CH3
CH3
Emulsan
Fig. 1 Chemical structure of the most studied microbial surface-active compounds; mono- and dirhamnolipids, acidic and lactonic sophorolipids,
monomycolates trehalose lipid and dimycolates trehalose lipids, mannosylerythritol lipids, surfactin and finally emulsan
Appl Microbiol Biotechnol (2010) 87:427–444 429
hydrocarbons through partitioning into micelles (Miller and with biodegradation similarly inhibited by Tween 20,
Zhang 1997; Volkering et al. 1998). sodium dodecyl sulfonate, tetradecyl trimethyl ammonium
High-molecular-weight biosurfactants (bioemulsifiers) bromide and Citrikleen at concentrations equal or greater
have great potential for stabilising emulsions between than their CMCs (Billingsley et al. 1999).
liquid hydrocarbons and water, thus increasing the surface Another proposed role of biosurfactants in hydrocarbon
area available for bacterial biodegradation. However, they uptake is the regulation of cell attachment to hydrophobic
have been rarely tested as enhancers of hydrocarbon and hydrophilic surfaces by exposing different parts of cell-
biodegradation in bioremediation systems, and contrasting bound biosurfactants, thus changing cell-surface hydropho-
results are reported in the literature (Barkay et al. 1999; bicity (Rosenberg et al. 1987; Franzetti et al. 2008a).
Franzetti et al. 2009a). This natural role can be exploited by adding (bio)
For low-molecular-weight biosurfactants, above the Crit- surfactants to increase the hydrophobicity of degrading
ical Micelle Concentration (CMC), a significant fraction of microorganisms and to allow cells’ easier access to
the hydrophobic contaminant partitions in the surfactant hydrophobic substrates (Shreve et al. 1995). The release
micelle cores. In some cases, this results in a general increase of LPS by Pseudomonas spp. induced by sub-CMC levels
in the bioavailability of contaminants for degrading micro- of rhamnolipids allowed a more efficient uptake of
organisms. Successful applications of rhamnolipids and hexadecane by rendering the cell surface more hydrophobic
surfactin in enhanced bioremediation have been recently (Al-Tahhan et al. 2000). Noordman and Janssen (2002)
reviewed (Mulligan 2009). In addition, Wang and Mulligan reported that rhamnolipid produced by P. aeruginosa UG2
(2009) studied the effect of ammonium ion concentration and facilitated the hydrocarbon uptake of the producer strain
pH on the potential application of rhamnolipid and surfactin and increased the degradation of hexadecane, while the
for enhanced biodegradation of diesel. A lipopeptide and same product did not stimulate to the same extent the
protein–starch–lipid produced by two strains of P. aeruginosa biodegradation of hexadecane by four unrelated species
significantly enhanced the solubilisation of phenanthrene, (Acinetobacter lwoffii RAG1, R. erythropolis ATCC 19558,
pyrene and fluorene, increasing their metabolism and R. erythropolis DSM 43066 and strain BCG112), nor was
supporting sustained growth (Bordoloi and Konwar 2009). degradation of hexadecane stimulated by addition of the
Polycyclic Aromatic Hydrocarbons (PAH) biodegradation biosurfactants produced by these species themselves.
was also investigated by Das et al. (2008b); they used Bacillus Zhong et al. (2007) showed that the adsorption of
circulans to increase the bioavailability of anthracene. dirhamnolipid biosurfactants on cells of B. subtilis, P.
Interestingly, the organism had better growth and biosurfac- aeruginosa and Candida lipolytica depended on the
tant production on glycerol containing mineral medium physiological status of the cells and was specific to the
supplemented with anthracene, although it was unable to microorganisms. Furthermore, the biosurfactant adsorp-
utilise anthracene as the sole carbon source. These authors tion affected the cell-surface hydrophobicity depending
were able to demonstrate, however, that anthracene was used on the rhamnolipid concentration and the physiological
as a substrate for the production of the biosurfactant. state of the cell. The effect of exogenous rhamnolipids
The specific modes of hydrocarbon uptake, however, are on cell-surface composition of P. aeruginosa NBIMCC
not fully understood. Recently Cameotra and Singh (2009) 1390 was recently studied by Sotirova et al. 2008. They
elucidated the mechanism of n-hexadecane uptake mediated showed that above the CMC, rhamnolipids caused a 22%
by rhamnolipids in P. aeruginosa. The rhamnolipids reduction of total cellular LPS content, while at concen-
produced an emulsion with hexadecane, thus facilitating trations below the CMC, they caused changes in the
increased contact between the hydrocarbon substrate and bacterial outer membrane protein composition yet did not
the bacteria. It was also observed that uptake of the affect the LPS component.
biosurfactant-coated hydrocarbon droplets occurred, sug- Chang et al. (2009) demonstrated that the cell-surface
gesting a mechanism like pinocytosis taking place, a hydrophobicity was enhanced by the accumulation at the
process not previously reported in bacterial hydrocarbon cell surface of different fatty acids during growth on
uptake systems. hydrocarbon in R. erythropolis NTU-1. A significant
In contrast, it is well known that the presence of a correlation between the modification of the cell surface by
surfactant can detrimentally affect biodegradation. Micelle saponins and the degree of hydrocarbon biodegradation was
cores can trap organic contaminants, creating a barrier reported by Kaczorek et al. (2008).
between microorganisms and organic molecules, resulting
in the potential substrate becoming less rather than more Biosurfactant-enhanced soil washing
available. For example, Witconol SN70, a non-ionic
alcohol ethoxylate surfactant (Colores et al. 2000), reduced The application of microbial SACs to remove contami-
the biodegradation rate of hexadecane and phenanthrene, nants from soils is a technology characterised by less
Appl Microbiol Biotechnol (2010) 87:427–444 431
system and genetic intervention is difficult. However, an are also used to retard staling, solubilise flavour oils and
alternative would be an in situ production of biosurfac- improve organoleptic properties in bakery and ice cream
tants, either by injected bacteria or by stimulated autoch- formulations and as fat stabilisers during cooking of fats.
thonous microorganisms. Therefore some effort has Although the addition of rhamnolipids has been suggested
recently been put into isolating new surfactant-producing to improve dough characteristics of bakery products, the
microbial strains using extreme conditions to reproduce use as food ingredients of compounds derived from an
those encountered in oil reservoirs (Agarwal and Sharma opportunistic pathogen such as P. aeruginosa is not
2009), while other research has focused on selective practically feasible. Instead, it has been suggested to use
activation of indigenous microorganisms able to enhance biosurfactants obtained from yeasts or Lactobacilli, which
oil recovery (Bao et al. 2009). The potential utilisation of are generally recognised as safe and are already involved
selected exogenous microoganisms can be assessed either in several food-processing technologies (Nitschke and
in the laboratory or directly in the field. The performance Costa 2007).
of two bacteria, B. subtilis and Leuconostoc mesenteroides, Wetting, dispersing and surface-tension reduction prop-
biosurfactant- and exopolymer-producing strains, respec- erties, as well as low toxicity and high biodegradability,
tively, were evaluated by using oil-saturated glass micro- suggested the application of biosurfactants, especially
models of a fractured porous medium to determine oil glycolipids, as components of detergent formulations.
recovery. B. subtilis gave better oil recovery due to the Low-foaming sophorolipids from C. bombicola appear
reduction of oil viscosity and the interfacial tension suitable due to their high detergency ability, low cytotox-
(Soudmand-Asli et al. 2007). icity and high biodegradability and general environmentally
While a number of field trials of in situ applications of acceptable properties (Hirata et al. 2009). Also, cyclic
MEOR are reported in the literature (see Sen 2008 for a lipopeptide biosurfactants from B. subtilis improved wash
review), it has not been completely elucidated whether performance by acting additively with other detergent
introduced microorganisms can actually be effective in oil components. Since they have shown better results at low
recovery or if they are out-competed by indigenous temperature, such formulations are promising from an
bacteria. The inability to compare test wells with control energy-saving point of view, allowing laundering at lower
wells subjected to similar treatment procedures without temperatures (Mukherjee 2007). Several surfactant–enzyme
introducing live microorganisms or products makes valid mixtures were tested for rubisco removal from both
conclusions difficult to draw. To provide better insight into hydrophobic and hydrophilic surfaces; the most effective
the dynamics of the microbial community, Wang et al. formulation was a surfactin–subtilisin A detergent, thus
(2008) monitored changes in the community using demonstrating that it would be possible to generate fully
molecular markers by denaturing gradient gel electropho- renewable cleaning formulations with good performance
resis in an oil reservoir during a process of MEOR. They (Onaizi et al. 2009).
observed that both exogenous and stimulated indigenous
bacteria appeared to contribute to the increased oil Biomedical applications
recovery.
Beside applications in MEOR, microbial surface-active Biosurfactants, when present in heterogeneous systems, tend
compounds can also be exploited for other applications in to aggregate at the phase boundaries or interfaces. Organic
the oil industry. For example, the de-emulsifying proper- molecules present in aqueous phase are known to be inclined
ties shown by some biosurfactant-producing microorgan- to immobilise at the solid interface is such interfacial
isms may be used to break emulsions which form at systems. They eventually form a conditioning film, which
various steps in oil extraction and processing, thus will affect the properties (surface energy and wettability) of
allowing a better recovery of the product. The surface- the original surface (Neu 1996). In a similar manner to
tension decrease produced by microbial surfactants can organic-conditioning films, biosurfactants partition at the
also be used to separate oil from tank bottom sludge interfaces and can affect the adhesion properties of micro-
(Singh et al. 2007; Joseph and Joseph 2009; Perfumo et al. organisms. Another function valuable for medical application
2010b). is their ability to disrupt membranes leading to cell lysis
Due to their physico-chemical properties, the use of through increased membrane permeability leading to metab-
microbial surface-active compounds has also been pro- olite leakage. This occurs due to changes in physical
posed for various industrial applications, as additives in membrane structure or through disrupting protein conforma-
foods, cosmetics and detergent formulations (Banat et al. tions which alters important membrane functions such as
2000). In the food industry, the most useful property is the transport and energy generation (Van Hamme et al. 2006;
ability to form stable emulsions, which improves the Ortiz et al. 2008, 2009; Sotirova et al. 2008; Sánchez et al.
texture and creaminess of dairy products. Biosurfactants 2009, 2010; Zaragoza et al. 2009).
Appl Microbiol Biotechnol (2010) 87:427–444 433
Biosurfactants as anti-adhesives silver used and greater antimicrobial activity. The concen-
tration of silver in the silver–biosurfactant solution was
Biofilm formation and swarming motility are the key from 129- to 258-fold less than the concentration when
microbial activities in the colonisation of a surface and silver was used alone. Based on these results, an interna-
therefore can increase the chance of nosocomial infections tional patent PCT/IB2009/055334 entitled “Biosurfactant
on different medical devices (Khardori and Yassien 1995; composition produced by a new B. licheniformis strain,
Vinh and Embil 2005; McCann et al. 2008; Harriott and uses and products thereof” has been deposited in 2009,
Noverr 2009). Current biofilm preventive strategies are inventors Martinotti M.G., Rivardo F. Allegrone G., Ceri
essentially aimed at coating medical surfaces with antimi- H., Turner R. Unpublished preliminary results obtained by
crobial agents (von Eiff et al. 2005; Basak et al. 2009). the same research group showed anti-adhesion effects of
However, recent studies have suggested that non-antibiotic two lipopeptides produced by bacterial endophytes, isolated
molecules naturally produced within bacterial communities, from oleander and rice, on the biofilm of two different
including secreted signalling molecules or surface-active pathogenic strains of C. albicans (Fig. 2).
biosurfactants, could also interfere with biofilm formation, Valle et al. (2006) observed that distinct serotypes of
modulating microbial interaction with interfaces (Neu 1996; group II capsular polysaccharides, produced by the uropa-
Federle and Bassler 2003; Rasmussen and Givskov 2006; thogenic E. coli (UPEC strain CFT073) behaved like
Rodrigues et al. 2006a). In addition to their direct action surface-active polymers that displayed anti-adhesion prop-
against pathogens, biosurfactants can also alter the physical erties. The treatment of abiotic surfaces with group II
and chemical condition of the environment where biofilms capsular polysaccharides significantly inhibit mature bio-
are developing (Mireles et al. 2001; Merk et al. 2005). film development of a broad range of Gram-positive and
Dealing with these biofilms is difficult yet an important Gram-negative bacteria.
goal, since microbes embedded within them are associated Strategies for the prevention of microbial biofilm formation
with many infections and usually become difficult to treat on silicone rubber voice prostheses on vinyl urethral catheters
effectively with traditional antimicrobials (Morikawa and on other material have also been described (Velraeds et al.
2006). 2000; Mireles et al. 2001; Rodrigues et al. 2004, 2006b, c,
Recently, the capability of two lipopeptide biosurfac- 2007).
tants, produced by B. subtilis V9T14 and B. licheniformis Beside treatment of medical devices, biosurfactants have
V19T21, to inhibit biofilm adhesion of pathogenic bacteria been used in the pre-treatment of material surfaces found in
to polystyrene was demonstrated using the MBEC device food-processing environments. Listeria monocytogenes,
(Rivardo et al. 2009). The two biosurfactants V9T14 and Salmonella enteritidis and Enterobacter sakazakii are
V19T21 showed interesting specific anti-adhesion activity examples of pathogenic bacteria implicated in outbreaks
being able to selectively inhibit biofilm formation by two associated with the ingestion of contaminated food.
pathogenic strains. In particular, S. aureus ATCC 29213 Numerous studies have shown that these bacteria are able
and Escherichia coli CFT073 biofilm formation were to adhere and to form biofilms on food-contact surfaces that
decreased by 97% and 90%, respectively. V9T14 biosur- are more resistant to sanitation than free-living cells
factant active on the Gram-negative strain was ineffective (Kalmokoff et al. 2001; Stepanovic et al. 2004; Kim et al.
against the Gram-positive and the opposite for V19T21 2006). The pre-conditioning of surfaces using microbial
biosurfactant. This activity was observed either by coating surface-active compounds could be an interesting strategy
the polystyrene surface or by adding the biosurfactant to the to prevent adhesion of food-borne pathogens to solid
inoculum. surfaces.
Two fractions from each purified biosurfactant, obtained Meylheuc et al. (2006b) demonstrated that the pre-
by flash chromatography, fractions (I) (surfactin) and (II) conditioning of stainless steel and polytetrafluoroethylene
(fengycin), showed that fraction (II) was responsible for the surfaces with an anionic biosurfactant produced by Pseu-
anti-adhesion activity in both strains. Moreover the V9T14 domonas fluorescens reduced the number of L. monocyto-
biosurfactant has been shown to increase biofilm eradica- genes LO28-adhering cells and thus resembled the
tion efficacy of different antibiotics against a urinary tract- bactericidal activities of the disinfectants sodium hypochlo-
infective E. coli strain (Martinotti et al. 2009—deposited rite (NaOCl) and peracetic acid/hydrogen peroxide (PAH).
patent). More recently, the activity of AgNO3 combined Similarly, the ability of adsorbed biosurfactants obtained
with the lipopeptide biosurfactant V9T14 has been studied from Lactobacillus helveticus and P. fluorescens to inhibit
against a preformed E. coli biofilm on the Calgary Biofilm the adhesion of four Listeria strains to stainless steel was
device (Rivardo et al. 2010). Results indicated that the investigated (Meylheuc et al. 2006a). Whichever strain of
activity of silver can be synergistically enhanced by the L. monocytogenes used in combination with biosurfactants,
presence of V9T14, allowing a reduction in the quantity of the anti-adhesive biological coating developed both reduced
Appl Microbiol Biotechnol (2010) 87:427–444 435
the total adhering flora and the viable and culturable aureus biofilm integrity and formation. Moreover, surfac-
adherent bacteria on stainless steel surfaces. More recently, tant addition to preformed mature biofilms accelerated their
another group investigated the effect of rhamnolipids and dispersal and altered the characteristics of the biofilm
surfactin biosurfactants on the adhesion of the food morphology.
pathogens E. sakazakii, L. monocytogenes and S. enteritidis Another interesting application field for probiotics that is
to polypropylene and stainless steel surfaces (Nitschke et al. gaining more interest is their use in preventing oral
2009a). Preconditioning with surfactin, rather than rhamno- infections. The role of probiotics on oral health has been
lipid, caused a reduction in the number of adhering cells thoroughly investigated (Çaglar et al. 2005; Meurman
particularly of L. monocytogenes and to some extent E. 2005; Meurman and Stamatova 2007; Hatakka et al.
sakazakii on stainless steel. Surfactin showed a significant 2007; Kõll et al. 2008). Van Hoogmoed et al. (2004)
decrease in the adhesion on polypropylene of all strains. demonstrated that Streptococcus mitis biosurfactant
The adsorption of surfactin on polystyrene also reduced the inhibited adhesion of Streptococcus sobrinus HG 1025
adhesion of S. enteritidis- and L. monocytogenes-growing and Streptococcus mutans ATCC 25175 to bare enamel,
cells. In addition, surfactin was able to delay bacterial while S. mitis biosurfactant was able to inhibit the adhesion
adhesion within short contact periods using non-growing of S. sobrinus HG 1025 to salivary pellicles. The authors
cells or longer contact periods using growing cells. later reported that these reductions may be attributed to
Probiotics have long been known for their antimicrobial increased electrostatic repulsion between the bacteria and
activity and for the capacity to interfere with the adhesion the biosurfactant-coated pellicles (Van Hoogmoed et al.
and formation of biofilms of pathogens to epithelial cells of 2006).
urogenital and intestinal tracts (Reid et al. 1998, 2001),
catheter materials (Hawthorn and Reid 1990) and voice Other biomedical and therapeutic applications
prostheses (Rodrigues et al. 2004, 2006b), and the
mechanisms of this interference have been demonstrated Biosurfactants have been shown to have many other roles in
to include, among others, the release of biosurfactants biomedical application. Surfactin is one of the most powerful
(Velraeds et al. 1996; Rodrigues et al. 2006d; Gudiña et al. biosurfactants and is known to have anti-inflammatory,
2010). Probiotics are thus well known to have a positive antibiotic and anti-tumour functions (Seydlová and Svobodová
effect on the maintenance of human health (Reid and 2008). Cao et al. (2010) demonstrated that surfactin induces
Burton 2002; Merk et al. 2005; Gupta and Garg 2009). apoptosis in human breast cancer MCF-7 cells through a
Recent work by Walencka et al. (2008) demonstrated ROS/JNK-mediated mitochondrial/caspase pathway, whereas
that surfactants obtained from three Lactobacillus acid- Byeon et al. (2008) observed that surfactin was able to down-
ophilus strains inhibited Staphylococcus epidermidis and S. regulate LPS-induced NO production in RAW264.7 cells and
436 Appl Microbiol Biotechnol (2010) 87:427–444
primary macrophages by inhibiting NF-κB activation. Park osomes. Their results suggested that MEL-A enhanced the
and Kim (2009) studied the role of surfactin in the inhibition association of lipoplexes with the cells, delivered them
of the immunostimulatory function of macrophages through widely into the cytoplasm and increased gene expression.
blocking the NK-κB, MAPK and Akt pathway. This Ueno et al. (2007a) observed that MEL-A-containing
provided a new insight into the immunopharmacological role liposomes exhibited high activity in DNA capsulation and
of surfactin in autoimmune disease and transplantation. Their membrane fusion with anionic liposomes, which are
work indicated that surfactin has potent immunosuppressive important properties for gene transfection. On the other
capabilities which suggested important therapeutic implica- hand, MEL-B- and MEL-C-containing liposomes only
tions for transplantation and autoimmune diseases, including increased either the capsulation or the membrane fusion.
allergy, arthritis and diabetes. In another work, Ueno et al. (2007b) suggested that MEL-A
Selvam et al. (2009) studied the effect of B. subtilis PB6, was capable of increasing and rapidly promoting the
a natural probiotic, on plasma cytokine levels in inflamma- transfection efficiency of target cells by inducing membrane
tory bowel disease and colon mucosal inflammation. The fusion between liposomes and the plasma membrane of
strain was found to secrete surfactins which are known to these cells.
inhibit phospholipase A2, involved in the pathophysiology In another work, a liposome vector containing beta-
of inflammatory bowel disease. In animal experiments sitosterol beta-D-glucoside biosurfactant-complexed DNA
carried out in rat models for trinitrobenzene sulfonic acid- was successfully used for herpes simplex virus thymidine
induced colitis, oral administration of PB6 as a probiotic kinase gene therapy (Maitani et al. 2006). More recently,
suppressed colitis as measured by mortality rate and nano-vectors containing a biosurfactant have been success-
changes in colon morphology and weight gain. Plasma fully used to increase the efficacy for gene transfection in
levels of pro-inflammatory cytokines were also significant- vitro and in vivo (Nakanishi et al. 2009). On the other hand,
ly lowered and the anti-inflammatory cytokine significantly Morita et al. (2009), using a three-dimensional cultured
increased after the oral administration of PB6, supporting human skin model, observed that the viability of the SDS-
the concept that PB6 inhibits PLA2 by secreting surfactins. damaged cells was markedly improved by the addition of
Han et al. 2008 observed that high surfactin micelle MEL-A in a dose-dependent manner. This demonstrated
concentration affected the aggregation of amyloid β-peptide that MEL-A had a ceramide-like moisturising activity
(Aβ (1-40)) into fibrils, a key pathological process toward the skin cells.
associated with Alzheimer’s disease. Another interesting Another interesting application for natural surfactant is
property of surfactin and its synthetic analogues is the the possibility to synthesise metal-bound nanoparticles
ability to alter the nanoscale organisation of supported using an environmentally friendly technology benign
bilayers and to induce nanoripple structures with intriguing (Palanisamy and Raichur 2009). The use of gold nano-
perspectives for biomedical and biotechnological applica- particles, in particular, is currently undergoing a dramatic
tions (Bouffioux et al. 2007; Brasseur et al. 2007; Francius expansion in the field of drug and gene delivery, targeted
et al. 2008). Fengycin, another lipopeptide biosurfactant is therapy and imaging (Pissuwan et al. 2009; Boisselier and
also able to cause membrane perturbations (Deleu et al. Astruc 2009). Recently, Reddy et al. (2009) synthesised, for
2008). Recent results by Eeman et al. (2009) emphasised the first time, surfactin-mediated gold nanoparticles, open-
the ability of fengycin to interact with the lipid constituents ing the way to a new and fascinating application of
of the stratum corneum extracellular matrix and with biosurfactants in the biomedical field. Most recently Smyth
cholesterol. et al. (2010c) reported on the production of selectively
The biological activities and the numerous potential deuterated rhamnolipids and sophorolipids using deuterated
applications of mannosylerythritol lipids (MELs), one of substrates. The production of such deuterated biosurfactants
the most promising glycolipid biosurfactants produced by in particular or other bioactive microbial products in
yeast strains of the genus Pseudozyma, have been thor- general in which distinct pattern of labelling could be
oughly discussed by Kitamoto et al. (2009). Imura et al. achieved would have great future implications with regards
(2007) and (2008), Ito et al. (2007) and Konishi et al. to efficacy and/or persistence or the development of
(2007a) developed and studied the kinetics of interactions resistance for some bioactives particularly in biomedical
in carbohydrate ligand systems composed of self-assembled related applications.
monolayers of mannosylerythritol lipid-A (MEL-A) from P.
antarctica serving as a high-affinity, easy to handle and
low-cost ligand system for immunoglobulin G and M and Production and optimisation
lectins. Igarashi et al. (2006) reported that MEL-A
significantly increased the cellular association and the Despite their environmentally favourable characteristics of
efficiency of gene transfection mediated by cationic lip- higher biodegradability, lower toxicity, better foaming
Appl Microbiol Biotechnol (2010) 87:427–444 437
properties compared to their synthetic chemical counter- costly or demanding downstream processing. Novel
parts while also showing better stability at extreme pH, strains able to produce biosurfactants on renewable and
salinity and temperature, the commercialisation of microbi- low-cost substrates have also been reported during the past
al surfactants has not been fully achieved largely due to few years. Ruggeri et al. (2009) isolated Rhodococcus sp.
production costs. At present, the production costs for most BS32 able to grow on rapeseed oil for the production of
biosurfactants do not compete with those of chemical extracellular biosurfactants. Glycerol, however, has
surfactants. Different strategies have been proposed to emerged as one important potential feedstock available
make the process more cost effective including: (1) in large quantities as a by-product of the biodiesel process
development of more efficient bioprocesses, including (Zheng et al. 2008).
optimisation of fermentative conditions and downstream Experimental design techniques have been extensively
recovery processes, (2) use of cheap and waste substrates used to optimise biosurfactant production. The use of
(Thavasi et al. 2007, 2008; Raza et al. 2009), (3) surface response methodology effectively enhanced the
development of overproducing strains (Fig. 3). The increas- production of biosurfactant by Rhodococcus spp. MTCC
ing number of reports of potential antimicrobial and anti- 2574 growing on n-hexadecane with yields of biosurfactant
adhesive properties of biosurfactants against pathogenic increasing from 3.2 to 10.9 g/L (Mutalik et al. 2008).
microorganisms (Rodrigues et al. 2006a) has added to the Working with Gordonia sp. BS29, Franzetti et al. (2009a)
impetus towards sustainability and reduced carbon foot increased the production of cell-bound glycolipids by 5-
prints (the greening process) which are helping drive the fold using surface response methodology, while the use of
market towards efficient large-scale production technolo- an artificial neutral network coupled with a genetic
gies. However, most biosurfactant research related to large- algorithm gave a 3.5-fold enhancement in biosurfactant
scale economic production trials has been mainly confined yield (Pal et al. 2009). The same methodologies were
to microorganisms, such as Pseudomonas, Bacillus and applied by Sivapathasekaran et al. (2010) aimed at
Candida (Mukherjee et al. 2006). optimising biosurfactant production by B. circulans MTCC
Several developments in optimisation of culture condi- 8281. Kronemberger et al. (2008) reported a significant
tions and downstream processing have been published increase in yield by optimising cultural conditions using
recently. The use of agroindustrial by-products has been statistical tools. They also reported that the yields may be
reported both for yeasts and bacteria (Makkar and Cameotra further enhanced by the development of new controlling
2002). Sobrinho et al. (2008) used ground nut oil refinery devices such as oxygen control.
residues and corn steep liquor as substrates for anionic Downstream processing accounts for most of the total
glycolipid production by Candida spherical, while the cost of a biotechnology product (Mukherjee et al. 2006).
biosynthesis of glycolipids by P. aeruginosa was obtained The most common isolation techniques for biosurfactants
using cashew apple juice as substrate (Rocha et al. 2007) use precipitation, solvent extraction and chromatographic
and vegetable oil refinery wastes (Raza et al. 2007). Very purification. Extraction of low-molecular-weight biosur-
high potential for large-scale industrial application was factant normally involves an optional precipitation step
achieved using the already commercialised Pharmamedia and the use of different organic solvents according to
medium for surfactin production by B. subtilis MZ-7 (Al- hydrophobicity and Hydrophilic-Lipophilic Balance
Ajiani et al. 2007). The use of substrates such as (HLB) value of the compounds. Rhamnolipids are usually
soapstick, frying oil and motor oil have all been explored precipitated by acidification and extracted using ethyl
and have had limited success due to the need for more acetate; extraction of sophorolipids is normally carried out
with n-hexane, while for trehalolipids, the preferred non-pathogenic P. putida (Cabrera-Valladares et al. 2006;
solvent is a mixture of chloroform and methanol. Cha et al. 2008). Wang et al. (2007) also reported the use of
Methanol is also used as a solvent for extraction of genetic engineering to obtain an E. coli and P. aeruginosa
lipopeptides after a precipitation by acidification (Smyth that were able to produce rhamnolipids after transposon-
et al. 2010a). High-molecular-weight biosurfactants are mediated chromosome integration of the rhamnosyltrasferase
usually extracted from the culture broth by ammonium 1 complex. Further yield increase could probably be obtained
sulphate precipitation and purified by dialysis. Other once the regulation mechanism of biosurfactant production is
techniques for high-molecular-weight biosurfactant isola- fully elucidated (Hsueh et al. 2007).
tion are TCA/acetone precipitation, acid ethanol and
chloroform/methanol (Smyth et al. 2010b). These techni-
ques are already well established for lab-scale applica- Conclusions and perspectives
tions, but their cost does not allow scaling-up for
industrial production of biosurfactants. For these reasons, In bioremediation, biosurfactant applications are limited even
the research effort is now directed towards the develop- though their high potential has been already demonstrated.
ment of low-cost extraction and purification procedures, This field will probably benefit more from recent and future
avoiding the use of hazardous and costly organic solvents. research on the mechanisms of interactions among hydro-
Many advances have been observed in very recent years carbons, surfactants and cells than from case-specific studies
for recovery and purification of lipopeptides (Smyth et al. about applicability of already-known biosurfactant com-
2010a, b). Sivapathasekaran et al. (2009) developed and pounds. In the food, biomedical and cosmetics area, in
optimised an efficient method for the separation and which high-value products are produced, the cost draw-
purification of fengycin isoforms using high-performance back could be less significant. The complex mixture of
liquid chromatography through manipulating the solvent different components produced by organisms hampers
gradient program and flow rates. Fengycin separation and applications, and further research is required to resolve
purification was also obtained directly from the cultivation specific issues. This field will have benefits from the very
step without the use of solvent and foam formation by recent attention paid to the isolation and characterisation of
pressing and harvesting the liquid surface layer (Glazyrina biosurfactants produced by extremophiles such as thermo-
et al. 2008). Dimitrov et al. (2008) applied liquid membrane philic and halophilic bacteria (Mnif et al. 2009, Joshi et al.
extraction processes for recovery of surfactin, achieving 2008; Kumar et al. 2008) aimed at the isolation of new
97% efficiency under optimised conditions. Chen and compounds with novel properties.
colleagues, in three different papers (Chen et al. 2008a, b; The proven antimicrobial, anti-adhesive, immune-
Chen and Juang 2008), optimised the recovery of surfactin modulating properties of biosurfactants and the recent
from fermentation broths of B. subtilis ATCC 21332 by successful applications in gene therapy, immunotherapy and
different methods and achieved improved purity by medical insertion safety suggest that it is worth persisting in
adsorption or ion exchange after the broth had been treated this field. Advances in the area of biomedical application are
by a two-stage ultrafiltration process. probably going to take the lead due to higher potential
With regards to the development of over producer economic returns. Moreover, due to their self-assembly
strains, genetic manipulation of selected strains remains properties, new and fascinating applications in nanotechnol-
limited. Although recombinant strains of Bacillus sp. and ogy are predicted for biosurfactants (Palanisamy 2008; Reddy
Acinetobacter sp. have been described, most genetic et al. 2009, Kitamoto et al. 2009). In-depth studies of their
manipulation efforts have been directed towards P. aerugi- natural roles in microbial competitive interactions, cell-to-cell
nosa due in part to its commercial potential and the more communication, pathogenesis, motility and biofilm formation
detailed knowledge of its genome. Random mutagenesis and maintenance could suggest future improved and interest-
using gamma-ray or N-methyl-N’-nitrosoguanidine in- ing applications.
creased rhamnolipid production two- to threefold compared The commercial success of microbial surfactants is
to wild strains (Mukherjee et al. 2006). currently limited by the high cost of production. Optimised
The ability to produce a hyper-producer strain of P. growth/production conditions using cheaper renewable
aeruginosa, however, is quite a difficult task due to the substrates and novel and efficient multi-step downstream
complexity of the transcriptional regulatory network of genes processing methods could make biosurfactant production
involved in rhamnolipid production. This is further compli- more profitable and economically feasible. Furthermore,
cated by the fact that rhamnolipids are produced as a mixture recombinant and mutant hyper-producer microbial strains,
of congeners. Attempts have been made to limit the products able to grow on a wide range of cheap substrates, could
to mono-rhamnolipids only through cloning the P. aerugi- produce biosurfactants in high yield and, potentially, bring
nosa rhlABRI operon into host organisms such as E. coli or the required breakthrough for their economic production.
Appl Microbiol Biotechnol (2010) 87:427–444 439
with potential applications in microbially enhanced oil recovery. Han Y, Huang X, Cao M, Wang Y (2008) Micellization of surfactin
Biotechnol Lett 30:263–270 and its effect on the aggregate conformation of amyloid β(1-40).
Debode J, De Maeyer K, Perneel M, Pannecoucque J, De Backer G, J Phys Chem B 112:15195–15201
Höfte M (2007) Biosurfactants are involved in the biological Harriott MM, Noverr MC (2009) Candida albicans and Staphylococ-
control of Verticillium microsclerotia by Pseudomonas spp. J cus aureus form polymicrobial biofilms: effects on antimicrobial
Appl Microbiol 103:1184–1196 resistance. Antimicrob Agents Chemother 53:3914–3922
Deleu M, Paquot M, Nylander T (2008) Effect of fengycin, a Hatakka K, Ahola AJ, Yli-Knuuttila H, Richardson M, Poussa T,
lipopeptide produced by Bacillus subtilis, on model biomem- Meurman JK (2007) Probiotics reduce the prevalence of oral
branes. Biophys J 94:2667–2679 Candida in the elderly—a randomized controlled trial. J Dent
Desai JD, Banat IM (1997) Microbial production of surfactants and Res 86:125–130
their commercial potential. Microbiol Mol Biol Rev 61:47–64 Hawthorn LA, Reid G (1990) Exclusion of uropathogen adhesion to
Dimitrov K, Gancel F, Montastruc L, Nikov I (2008) Liquid polymer surfaces by Lactobacillus acidophilus. J Biomed Mater
membrane extraction of bio-active amphiphilic substances: Res 24:39–46
recovery of surfactin. Biochem Eng J 42:248–253 Hirata Y, Ryu M, Oda Y, Igarashi K, Nagatsuka A, Furuta T, Sugiura
Eeman M, Francius G, Dufrêne YF, Nott K, Paquot M, Deleu M M (2009) Novel characteristics of sophorolipids, yeast glycolipid
(2009) Effect of cholesterol and fatty acids on the molecular biosurfactants, as biodegradable low-foaming surfactants. J
interactions of fengycin with stratum corneum mimicking lipid Biosci Bioeng 108:142–146
monolayers. Langmuir 25:3029–3039 Hong HA, Duc LH, Cutting SM (2005) The use of bacterial spore
Federle MJ, Bassler BL (2003) Interspecies communication in formers as probiotics. FEMS Microbiol Rev 29:813–835
bacteria. J Clin Invest 112:1291–1299 Hsueh YH, Somers EB, Lereclus D, Ghelardi E, Wong ACL (2007)
Francius G, Dufour S, Deleu M, Paquot M, Mingeot-Leclercq MP, Biosurfactant production and surface translocation are regulated
Dufrêne YF (2008) Nanoscale membrane activity of surfactins: by PlcR in Bacillus cereus ATCC 14579 under low-nutrient
influence of geometry, charge and hydrophobicity. Biochim conditions. Appl Environ Microbiol 73:7225–7231
Biophys Acta 1778:2058–2068 Huang X, Lu Z, Zhao H, Bie X, Lü FX, Yang S (2006) Antiviral
Franzetti A, Di Gennaro P, Bevilacqua A, Papacchini M, Bestetti G activity of antimicrobial lipopeptide from Bacillus subtilis fmbj
(2006) Environmental features of two commercial surfactants against pseudorabies virus, porcine parvovirus, newcastle disease
widely used in soil remediation. Chemosphere 62:1474–1480 virus and infectious bursal disease virus in vitro. Int J Pept Res
Franzetti A, Bestetti G, Caredda P, La Colla P, Tamburini E (2008a) Ther 12:373–377
Surface-active compounds and their role in the access to Huang X, Lu Z, Bie X, Lü F, Zhao H, Yang S (2007) Optimization of
hydrocarbons in Gordonia strains. FEMS Microbiol Ecol inactivation of endospores of Bacillus cereus by antimicrobial
63:238–248 lipopeptides from Bacillus subtilis fmbj strains using a response
Franzetti A, Di Gennaro P, Bestetti G, Lasagni A, Pitea D, Collina E surface method. Appl Microbiol Biotechnol 74:454–461
(2008b) Selection of surfactants for enhancing diesel Igarashi S, Hattori Y, Maitani Y (2006) Biosurfactant MEL-A
hydrocarbons-contaminated media bioremediation. J Hazard enhances cellular association and gene transfection by cationic
Mater 152:1309–1316 liposome. J Control Release 112:362–368
Franzetti A, Caredda P, Ruggeri C, La Colla P, Tamburini E, Imura T, Ito S, Azumi R, Yanagishita H, Sakai H, Abe M, Kitamoto D
Papacchini M, Bestetti G (2009a) Potential applications of (2007) Monolayers assembled from a glycolipid biosurfactant
surface active compounds by Gordonia sp. strain BS29 in soil from Pseudozyma (Candida) antarctica serve as a high-affinity
remediation technologies. Chemosphere 75:810–807 ligand system for immunoglobulin G and M. Biotechnol Lett
Franzetti A, Caredda P, La Colla P, Pintus M, Tamburini E, Papacchini 29:865–870
M, Bestetti G (2009b) Cultural factor affecting biosurfactant Imura T, Masuda Y, Ito S, Worakitkanchanakul W, Morita T, Fukuoka
production by Gordonia sp. BS29. Int Biodeterior Biodegrad T, Sakai H, Abe M, Kitamoto D (2008) Packing density of
63:943–947 glycolipid biosurfactant monolayers give a significant effect on
Franzetti A, Tamburini E, Banat IM (2010) Application of biological their binding affinity toward immunoglobulin G. J Oleo Sci
surface active compounds in remediation technologies. In: Sen R 57:415–422
(ed) Biosurfactants, ‘Advances in experimental medicine and Ito S, Imura T, Fukuoka T, Morita T, Sakai H, Abe M, Kitamoto D
biology’, vol 672. Springer, Berlin, pp 121–134 (2007) Kinetic studies on the interactions between glycolipid
Glazyrina J, Junne S, Thiesen P, Lunkenheumer K, Goetz P (2008) In biosurfactant assembled monolayers and various classes of
situ removal and purification of biosurfactants by automated immunoglobulins using surface plasmon resonance. Colloids
surface enrichment. Appl Microbiol Biotechnol 81:23–31 Surf B Bionterfaces 58:165–171
Grangemard I, Wallach J, Maget-Dana R, Peypoux F (2001) Lichen- Joseph PJ, Joseph A (2009) Microbial enhanced separation of oil
ysin: a more efficient cation chelator than surfactin. Appl from a petroleum refinery sludge. J Hazard Mater 161:522–
Biochem Biotechnol 90:199–210 525
Grover M, Nain L, Singh SB, Saxena AK (2010) Molecular and Joshi S, Bharucha C, Jha S, Yadav S, Nerurkar A, Desai AJ (2008)
biochemical approaches for characterization of antifungal trait of Biosurfactant production using molasses and whey under
a potent biocontrol agent Bacillus subtilis RP24. Curr Microbiol thermophilic conditions. Bioresour Technol 99:195–199
60:99–106 Kaczorek E, Chrzanowski L, Pijanowska A, Oluanowski A (2008)
Gudiña EJ, Teixeira JA, Rodrigues LR (2010) Isolation and functional Yeast and bacteria cell hydrophobicity and hydrocarbon biodeg-
characterization of a biosurfactant produced by Lactobacillus radation in the presence of natural surfactants: Rhamnolipids and
paracasei. Colloids Surf B Biointerfaces 76:298–304 saponins. Bioresource Technol 99:4285–4291
Gupta V, Garg R (2009) Probiotics. Indian J Med Microbiol 27:202– Kalmokoff ML, Austin JW, Wan XD, Sanders G, Banerjee S, Farber
209 JM (2001) Adsoption, attachment and biofilm formation among
Haddadin MSY, Abou Arqoub AA, Abu Reesh I, Haddadin J (2009) isolates of Listeria monocytogenes using model conditions. J
Kinetics of hydrocarbon extraction from oil shale using bio- Appl Microbiol 91:725–734
surfactant producing bacteria. Energy Convers Manag 50:983– Khardori N, Yassien MJ (1995) Biofilms in device-related infections. J
990 Ind Microbiol 15:141–147
Appl Microbiol Biotechnol (2010) 87:427–444 441
Kim K, Yoo D, Kim Y, Lee B, Shin D, Kim E-K (2002) Character- Meurman JH, Stamatova I (2007) Probiotics: contributions to oral
istics sophorolipid as an antimicrobial agent. J Microbiol health. Oral Dis 13:443–445
Biotechnol 12:235–241 Meylheuc T, Methivier C, Renault M, Herry JM, Pradier CM,
Kim H, Ryu JH, Beuchat LR (2006) Attachment of and biofilm Bellon-Fontaine MN (2006a) Adsorption on stainless steel
formation by Enterobacter sakazakii on stainless steel and enteral surfaces of biosurfactants produced by gram-negative and
feeding tubes. Appl Environ Microbiol 72:5846–5856 gram-positive bacteria: consequence on the bioadhesive be-
Kitamoto D, Yanagishita H, Shinbo T, Nakane T, Kamisawa C, havior of Listeria monocytogenes. Colloids Surf B Biointerfa-
Nakahara T (1993) Surface active properties and antimicrobial ces 52:128–137
activities of mannosylerythritol lipids as biosurfactants produced Meylheuc T, Renault M, Bellon-Fontaine MN (2006b) Adsorption of
by Candida antarctica. J Biotechnol 29:91–96 a biosurfactant on surfaces to enhance the disinfection of surfaces
Kitamoto D, Morita T, Fukuoka T, Konishi M, Imura T (2009) Self- contaminated with Listeria monocytogenes. Int J Food Microbiol
assembling properties of glycolipid biosurfactants and their 109:71–78
potential applications. Curr Opin Colloid Interface Sci 14:315– Miller RM, Zhang Y (1997) Measurement of biosurfactant-enhanced
328 solubilization and biodegradation of hydrocarbons, bioremedia-
Kõll P, Mändar R, Marcotte H, Leibur E, Mikelsaar M, Hammar- tion protocols. Humana Press, New Jersey, pp 59–66
ström L (2008) Characterization of oral lactobacilli as Mimee B, Labbé C, Pelletier R, Bélanger RR (2005) Antifungal
potential probiotics for oral health. Oral Microbiol Immunol activity of flocculosin, a novel glycolipid isolated from Pseudo-
23:139–147 zyma flocculosa. Antimicrob Agents Chemother 49:1597–1599
Konishi M, Imura T, Fukuoka T, Morita T, Kitamoto D (2007a) A Mimee B, Pelletier R, Bélanger RR (2009) In vitro antibacterial
yeast glycolipid biosurfactant, mannosylerythritol lipid, shows activity and antifungal mode of action of flocculosin, a
high binding affinity towards lectins on a self-assembled membrane-active cellobiose lipid. J Appl Microbiol 107:989–996
monolayer system. Biotechnol Lett 29:473–480 Mireles JR II, Toguchi A, Harshey RM (2001) Salmonella enterica
Konishi M, Morita T, Fukuoha T, Imura T, Kakugawa K, Kitamoto D serovar typhimurium swarming mutants with altered biofilm
(2007b) Production of different types of mannosylerythritol lipids forming abilities: surfactin inhibits biofilm formation. J Bacteriol
as biosurfactant by the newly isolated yeast strains belonging to 183:5848–5854
the genus Pseudozyma. Appl Microbiol Biotechnol 75:521–531 Mnif S, Chamkha M, Sayadi S (2009) Isolation and characterization
Kronemberger FD, Anna L, Fernandes A, de Menezes RR, Borges CP, of Halomonas sp strain C2SS100, a hydrocarbon-degrading
Freire DMG (2008) Oxygen-controlled biosurfactant production bacterium under hypersaline conditions. J Appl Microbiol
in a bench scale bioreactor. Appl Biochem Biotechnol 147:33– 107:785–794
45 Mohammadipour M, Mousivand M, Salehi Jouzani G, Abbasaliza-
Kulakovskaya T, Shashkov A, Kulakovskaya E, Golubev W, Zinin A, deh S (2009) Molecular and biochemical characterization of
Tsvetkov Y, Grachev A, Nifantiev N (2009) Extracellular Iranian surfactin-producing Bacillus subtilis isolates and eval-
cellobiose lipid from yeast and their analogues: structures and uation of their biocontrol potential against Aspergillus flavus
fungicidal activities. J Oleo Sci 58:133–140 and Colletotrichum gloeosporioides. Can J Microbiol 55:395–
Kulakovskaya TV, Golubev WI, Tomashevskaya MA, Kulakovskaya 404
EV, Shashkov AS, Grachev AA, Chizhov AS, Nifantiev NE Morikawa M (2006) Beneficial biofilm formation by industrial
(2010) Production of antifungal cellobiose lipids by Tricho- bacteria Bacillus subtilis and related species. J Biosci Bioeng
sporon porosum. Mycopathologia 169:117–123 101:1–8
Kumar M, Leon V, Materano ADS, Ilzins OA, Luis L (2008) Morita T, Kitagawa M, Suzuki M, Yamamoto S, Sogabe A,
Biosurfactant production and hydrocarbon-degradation by hal- Yanagidani S, Imura T, Fukuoka T, Kitamoto D (2009) A yeast
otolerant and thermotolerant Pseudomonas sp. World J Microbiol glycolipid biosurfactant, mannosylerythritol lipid, shows poten-
Biotechnol 24:1047–1057 tial moisturizing activity toward cultured human skin cells: the
Landman D, Georgescu C, Martin DA, Quale J (2008) Polymyxins recovery effect of MEL-A on the SDS-damaged human skin
revisited. Clin Microbiol Rev 21:449–465 cells. J Oleo Sci 58:639–642
Maier RM, Soberón-Chávez G (2000) Pseudomonas aeruginosa Mukherjee AK (2007) Potential application of cyclic lipopeptide
rhamnolipids: biosynthesis and potential applications. Appl biosurfactants produced by Bacillus subtilis in laundry detergent
Microbiol Biotechnol 54:625–633 formulations. Lett Appl Microbiol 45:330–335
Maitani Y, Yano S, Hattori Y, Furuhata M, Hayashi K (2006) Mukherjee S, Das P, Sen R (2006) Towards commercial production of
Liposome vector containing biosurfactant-complexed DNA as microbial surfactants. Trends Biotechnol 24:509–515
herpes simplex virus thymidine kinase gene delivery system. J Mulligan CN (2009) Recent advances in the environmental applica-
Liposome Res 16:359–372 tions of biosurfactants. Curr Opin Colloid Interface Sci 14:372–
Makkar RS, Cameotra SS (2002) An update on the use of 378
unconventional substrates for biosurfactant production and their Mutalik SR, Vaidya BK, Joshi RM, Dsai KM, Nene SN (2008) Use of
new applications. Appl Microbiol Biot 58:428–434 response surface optimization for the production of biosurfactant
Martinotti MG, Rivardo F Allegrone G, Ceri H, Turner R (2009) from Rhodococcus spp. MTCC 2574. Bioresour Technol
Biosurfactant composition produced by a new Bacillus lichen- 99:7875–7880
iformis strain, uses and products thereof. International patent Nakanishi M, Inoh Y, Kitamoto D, Furuno T (2009) Nano vectors
PCT/IB2009/055334 25 November with a biosurfactant for gene transfection and drug delivery. J
McCann MT, Gilmore BF, Gorman SP (2008) Staphylococcus Drug Delivery Sci Technol 19:165–169
epidermidis device-related infections: pathogenesis and clinical Naruse N, Tenmyo O, Kobaru S, Kamei H, Miyaki T, Konishi M, Oki
management. J Pharm Pharmacol 60:1551–1571 T (1990) Pumilacidin, a complex of new antiviral antibiotics:
Merk K, Borelli C, Korting HC (2005) Lactobacilli—bacteria–host production, isolation, chemical properties, structure and biolog-
interactions with special regard to the urogenital tract. Int J Med ical activity. J Antibiot (Tokyo) 43:267–280
Microbiol 295:9–18 Neu TR (1996) Significance of bacterial surface-active compounds in
Meurman JH (2005) Probiotics: do they have a role in oral medicine interaction of bacteria with interfaces. Microbiol Rev 60:151–
and dentistry? Eur J Oral Sci 113:188–196 166
442 Appl Microbiol Biotechnol (2010) 87:427–444
Neu T, Hartner T, Poralla K (1990) Surface active properties of Rasmussen TB, Givskov M (2006) Quorum-sensing inhibitors as anti-
viscosin: a peptidolipid antibiotic. Appl Microbiol Biotechnol pathogenic drugs. Int J Med Microbiol 296:149–161
32:518–520 Raza ZA, Rehman A, Khan MS, Khalid ZM (2007) Improved
Nitschke M, Costa SGVAO (2007) Biosurfactants in food industry. production of biosurfactant by Pseudomonas aeruginosa
Trends Food Sci Technol 18:252–259 mutant using vegetable oil refinery wastes. Biodegradation
Nitschke M, Araújo LV, Costa SG, Pires RC, Zeraik AE, Fernandes 18:115–121
AC, Freire DM, Contiero J (2009a) Surfactin reduces the Raza ZA, Khalid ZM, Banat IM (2009) Characterization of rhamno-
adhesion of food-borne pathogenic bacteria to solid surfaces. lipids produced by a Pseudomonas aeruginosa mutant strain
Lett Appl Microbiol 49:241–247 grown on waste oils. J Environ Sci Health Part A—Toxic/Hazard
Nitschke M, Costa SG, Contiero J (2009b) Structure and applications Substances Environ Eng 44:1367–1373
of a rhamnolipid surfactant produced in soybean oil waste. Appl Reddy AS, Chen CY, Chen CC, Jean JS, Fan CW, Chen HR, Wang
Biochem Biotechnol 160:2066–2074. doi:10.1007/s12010-009- JC, Nimje VR (2009) Synthesis of gold nanoparticles via an
8707-8 environmentally benign route using a biosurfactant. J Nanosci
Noordman WH, Janssen DB (2002) Rhamnolipid stimulates uptake of Nanotechnol 9:6693–6699
hydrophobic compounds by Pseudomonas aeruginosa. Appl Reid G, Burton J (2002) Use of Lactobacillus to prevent infection by
Environ Microbiol 68:4502–4508 pathogenic bacteria. Microbes Infect 4:319–324
Onaizi SA, He L, Middelberg APJ (2009) Rapid screening of Reid G, Bruce A, Smeianov V (1998) The role of Lactobacilli in
surfactant and biosurfactant surface cleaning performance. preventing urogenital and intestinal infections. Int Dairy J 8:555–
Colloid Surf B 72:68–74 562
Ortiz A, Teruel JA, Espuny MJ, Marqués A, Manresa Á, Aranda FJ Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B
(2008) Interactions of a Rhodococcus sp. biosurfactant trehalose (2001) Oral probiotics can resolve urogenital infections. FEMS
lipid with phosphatidylethanolamine membranes. Biochim Bio- Immunol Med Microbiol 30:49–52
phys Acta 1778:2806–2813 Remichkova M, Galabova D, Roeva I, Karpenko E, Shulga A,
Ortiz A, Teruel JA, Espuny MJ, Marqués A, Manresa Á, Arand FJ Galabov AS (2008) Anti-herpesvirus activities of Pseudomonas
(2009) Interactions of a bacterial biosurfactant trehalose lipid sp. S-17 rhamnolipid and its complex with alginate. Z Natur-
with phosphatidylserine membranes. Chem Phys Lipids 158:46– forsch C 63:75–81
53 Rivardo F, Turner RJ, Allegrone G, Ceri H, Martinotti MG (2009)
Pal MP, Vaidya BK, Desai KM, Joshi RM, Nene SN, Kulkarni BD Anti-adhesion activity of two biosurfactants produced by
(2009) Media optimization for biosurfactant production by Bacillus spp. prevents biofilm formation of human bacterial
Rhodococcus erythropolis MTCC 2794: artificial intelligence pathogens. Appl Microbiol Biotechnol 83:541–553
versus a statistical approach. J Ind Microbiol Biotech 36:747– Rivardo F, Martinotti MG, Raymond Joseph Turner RJ, Ceri H (2010)
756 The activity of silver against Escherichia coli biofilm is increased
Palanisamy P (2008) Biosurfactant mediated synthesis of NiO nano- by a lipopeptide biosurfactant. Can J Microbiol 56(3):272–278.
rods. Mat Lett 62:743–746 doi:10.1139/W10-007
Palanisamy P, Raichur AM (2009) Synthesis of spherical NiO Rocha MV, Souza MCM, Benedicto SC, Bezerra MS, Macedo GR,
nanoparticles through a novel biosurfactant mediated emulsion Pinto GAS, Goncalves LRB (2007) Production of biosurfactant
technique. Mater Sci Eng C Biomim Supramol Syst 29:199–204 by Pseudomonas aeruginosa grown on cashew apple juice. Appl
Paria S (2008) Surfactant-enhanced remediation of organic contami- Biochem Biotechnol 137–140:185–194
nated soil and water. Adv Colloid Interface Sci 138:24–58 Rodrigues L, van der Mei HC, Teixeira J, Oliveira R (2004)
Park SY, Kim Y (2009) Surfactin inhibits immunostimulatory function Influence of biosurfactants from probiotic bacteria on forma-
of macrophages through blocking NK-κB, MAPK and Akt tion of biofilms on voice prostheses. Appl Environ Microbiol
pathway. Int Immunopharmacol 9:886–893 70:4408–4410
Peng F, Liu Z, Wang L, Shao Z (2007) An oil-degrading bacterium: Rodrigues L, Banat IM, Teixeira J, Oliveira R (2006a) Biosurfactants:
Rhodococcus erythropolis strain 3C-9 and its biosurfactants. J potential applications in medicine. J Antimicrob Chemother
Appl Microbiol 102:1603–1611 57:609–618
Perfumo A, Smyth TJP, Marchant R, Banat IM (2010a) Production Rodrigues L, van der Mei H, Banat IM, Teixeira J, Oliveira R (2006b)
and roles of biosurfactants and bioemulsifiers in accessing Inhibition of microbial adhesion to silicone rubber treated with
hydrophobic substrates. In: Timmis KN (ed) Handbook of biosurfactant from Streptococcus thermophilus A. FEMS Immu-
hydrocarbon and lipid microbiology. Springer, Berlin, pp 1501– nol Med Microbiol 46:107–112
1512 Rodrigues LR, Banat IM, van der Mei HC, Teixeira JA, Oliveira R,
Perfumo A, Rancich I, Banat IM (2010b) Possibilities and challenges Oliveira R (2006c) Interference in adhesion of bacteria and
for biosurfactants use in petroleum industry, vol 672. In: Sen R yeasts isolated from explanted voice prostheses to silicone rubber
(ed) Biosurfactants’ advances in experimental medicine and by rhamnolipid biosurfactants. J Appl Microbiol 100:470–
biology. Springer, Berlin, pp 135–157 480
Pissuwan D, Niidome T, Cortie MB (2009) The forthcoming Rodrigues LR, Teixeira JA, van der Mei HC, Oliveira R (2006d)
applications of gold nanoparticles in drug and gene delivery Physicochemical and functional characterization of a biosurfac-
systems. J Control Release (in press) tant produced by Lactococcus lactis 53. Colloids Surf B
Pornsunthorntawee O, Arttaweeporn N, Paisanjit S, Somboonthanate Biointerfaces 49:79–86
P, Abe M, Rujiravanit R, Chavadej S (2008) Isolation and Rodrigues L, Banat IM, Teixeira J, Oliveira R (2007) Strategies for the
comparison of biosurfactants produced by Bacillus subtilis PT2 prevention of microbial biofilm formation on silicone rubber
and Pseudomonas aeruginosa SP4 for microbial surfactant- voice prostheses. J Biomed Mater Res B Appl Biomater 81:358–
enhanced oil recovery. Biochem Eng J 42:172–179 370
Rapp P, Bock H, Wray V, Wagner F (1979) Formation, isolation Rosenberg E, Ron EZ (1997) Bioemulsans: microbial polymeric
and characterisation of trehalose dimycolates from Rhodococ- emulsifiers. Curr Opin Biotechnol 8:313–316
cus erythropolis grown on n-alkanes. J Gen Microbiol 115:491– Rosenberg E, Ron EZ (1999) High- and low-molecular-mass
503 microbial surfactants. Appl Microbiol Biotechnol 52:154–162
Appl Microbiol Biotechnol (2010) 87:427–444 443
Rosenberg E, Rubinovitz C, Legmann R, Ron EZ (1987) Purification Snook ME, Mitchell T, Hinton DM, Bacon CW (2009) Isolation and
and chemical properties of Acinetobacter calcoaceticus A2 characterization of Leu7-surfactin from the endophytic bacterium
biodispersan. Appl Environ Microbiol 54:323–326 Bacillus mojavensis RRC 101, a biocontrol agent for Fusarium
Ruggeri C, Franzetti A, Bestetti G, Caredda P, La Colla P, Pintus M, verticillioides. J Agric Food Chem 57:4287–4292
Sergi S, Tamburini E (2009) Isolation and characterisation of Sobrinho HBS, Rufino RD, Luna JM, Salgueiro AA, Campos-Takaki
surface active compound-producing bacteria from hydrocarbon- GM, Leite LFC, Sarubbo LA (2008) Utilization of two agro-
contaminated environments by a high-throughput screening industrial by-products for the production of a surfactant by
procedure. Int Biodeterior Biodegrad 63:936–942 Candida sphaerica UCP0995. Process Biochem 43:912–917
Saini HS, Barragán-Huerta BE, Lebrón-Paler A, Pemberton JE, Sotirova AV, Spasova DI, Galabova DN, Karpenko E, Shulga A
Vázquez RR, Burns AM, Marron MT, Seliga CJ, Gunatilaka (2008) Rhamnolipid–biosurfactant permeabilizing effects on
AA, Maier RM (2008) Efficient purification of the biosurfactant gram-positive and gram-negative bacterial strains. Curr Micro-
viscosin from Pseudomonas libanensis strain M9-3 and its biol 56:639–644
physicochemical and biological properties. J Nat Prod 71:1011– Soudmand-Asli A, Ayatollahi SS, Mohabatkar H, Zareie M, Shar-
1015 iatpanahi SF (2007) The in situ microbial enhanced oil recovery
Sánchez M, Aranda FJ, Teruel JA, Ortiz A (2009) Interaction of a in fractured porous media. J Pet Sci Eng 58:161–172
bacterial dirhamnolipid with phosphatidylcholine membranes: a Stepanovic S, Cirkovic I, Ranin L, Svabic-Vlahovic M (2004) Biofilm
biophysical study. Chem Phys Lipids 161:51–55 formation by Salmonella spp. and Listeria monocytogenes on
Sánchez M, Aranda FJ, Teruel JA, Espuny MJ, Marqués A, Manresa plastic surface. Lett Appl Microbiol 38:428–432
Á, Ortiz A (2010) Permeabilization of biological and artificial Suthar H, Hingurao K, Desai A, Nerurkar A (2008) Evaluation of
membranes by a bacterial dirhamnolipid produced by Pseudo- bioemulsifier mediated microbial enhanced oil recovery using
monas aeruginosa. J Colloid Interface Sci 341:240–247 sand pack column. J Microbiol Methods 75:225–230
Selvam R, Maheswari P, Kavitha P, Ravichandran M, Sas B, Tanaka Y, Tojo T, Uchida K, Uno J, Uchida Y, Shida O (1997)
Ramchand CN (2009) Effect of Bacillus subtilis PB6, a natural Method of producing iturin A and antifungal agent for profound
probiotic on colon mucosal inflammation and plasma cytokines mycosis. Biotechnol Adv 15:234–235
levels in inflammatory bowel disease. Indian J Biochem Biophys Teichmann B, Linne U, Hewald S, Marahiel MA, Bölker M (2007) A
46:79–85 biosynthetic gene cluster for a secreted cellobiose lipid with
Sen R (2008) Biotechnology in petroleum recovery: the microbial antifungal activity from Ustilago maydis. Mol Microbiol 66:525–
EOR. Prog Energ Combust 34:714–724 533
Seydlová G, Svobodová J (2008) Review of surfactin chemical Thavasi R, Jayalakshmi S, Balasubramanian T, Banat IM (2007)
properties and the potential biomedical applications. Cent Eur J Biosurfactant production by Corynebacterium kutscheri from
Med 3:123–133 waste motor lubricant oil and peanut oil cake. Lett Appl
Shah V, Doncel GF, Seyoum T, Eaton KM, Zalenskaya I, Hagver R, Microbiol 45:686–691
Azim A, Gross R (2005) Sophorolipids, microbial glycolipids Thavasi R, Jayalakshmi S, Balasubramanian T, Banat IM (2008)
with anti-human immunodeficiency virus and sperm- Production and characterization of a glycolipid biosurfactant
immobilizing activities. Antimicrob Agents Chemother from Bacillus megaterium using economically cheaper sources.
49:4093–4100 World J Microbiol Biotechnol 24:917–925
Shreve GS, Inguva S, Gunnan S (1995) Rhamnolipid biosurfactant Tiehm A (1994) Degradation of polycyclic aromatic hydrocarbons in
enhancement of hexadecane biodegradation by Pseudomonas the presence of synthetic surfactants. Appl Environ Microbiol
aeruginosa. Mol Mar Biol Biotechnol 4:331–337 60:258–263
Singh P, Cameotra SS (2004) Potential applications of microbial Tran H, Ficke A, Asiimwe T, Höfte M, Raaijmakers JM (2007) Role
surfactants in biomedical sciences. Trends Biotechnol 22:142– of cyclic lipopeptide massetolide A in biological control of
146 Phytophthora infestans and in colonization of tomato plants by
Singh A, van Hamme JD, Ward OP (2007) Surfactants in microbiol- Pseudomonas fluorescens. New Phytol 175:731–742
ogy and biotechnology: part 2. Application aspects. Biotechnol Tran H, Kruijt M, Raaijmakers JM (2008) Diversity and activity of
Adv 25:99–121 biosurfactant-producing Pseudomonas in the rhizosphere of black
Sivapathasekaran C, Mukherjee S, Samanta R, Sen R (2009) High- pepper in Vietnam. J Appl Microbiol 104:839–851
performance liquid chromatography purification of biosurfactant Ueno Y, Hirashima N, Inoh Y, Furuno T, Nakanishi M (2007a)
isoforms produced by a marine bacterium. Anal Bioanal Chem Characterization of biosurfactant-containing liposomes and their
395:845–854 efficiency for gene transfection. Biol Pharm Bull 30:169–172
Sivapathasekaran C, Mukherjee S, Ray A, Gupta A, Sen R (2010) Ueno Y, Inoh Y, Furuno T, Hirashima N, Kitamoto D, Nakanishi M
Artificial neural network modeling and genetic algorithm based (2007b) NBD-conjugated biosurfactant (MEL-A) shows a new
medium optimization for the improved production of marine pathway for transfection. J Control Release 123:247–253
biosurfactant. Bioresour Technol 101:2884–2887 Valle J, Da Re S, Henry N, Fontaine T, Balestrino D, Latour-Lambert
Smyth TJP, Perfumo A, Marchant R, Banat IM (2010a) Isolation and P, Ghigo JM (2006) Broad-spectrum biofilm inhibition by a
analysis of low molecular weight microbial glycolipids. In: secreted bacterial polysaccharide. Proc Natl Acad Sci U S A
Timmis KN (ed) Handbook of hydrocarbon and lipid microbiol- 103:12558–12563
ogy. Springer, Berlin, pp 3705–3723 Van Bogaert INA, Saerens K, De Muynck C, Develter D, Wim S,
Smyth TJP, Perfumo A, McClean S, Marchant R, Banat IM (2010b) Vandamme EJ (2007) Microbial production and application of
Isolation and analysis of lipopeptides and high molecular weight sophorolipids. Appl Microbiol Biotechnol 76:23–34
biosurfactants. In: Timmis KN (ed) Handbook of hydrocarbon Van Hamme JD, Singh A, Ward OP (2006) Physiological aspects Part
and lipid microbiology. Springer, Berlin, pp 3689–3704 1 in a series of papers devoted to surfactants in microbiology and
Smyth TJ, Perfumo A, Marchant R, Banat IM, Chen M, Thomas RK, biotechnology. Biotechnol Adv 24:604–620
Penfold J, Stevenson PS, Parry NJ (2010c) Directed microbial Van Hoogmoed CG, Van der Mei HC, Busscher HJ (2004) The
biosynthesis of deuterated biosurfactants and potential future influence of biosurfactants released by S. mitis BMS on the
application to other bioactive molecules. Appl Microbiol Bio- adhesion of pioneer strains and cariogenic bacteria. Biofouling
technol (in press) 20:261–267
444 Appl Microbiol Biotechnol (2010) 87:427–444
Van Hoogmoed CG, Dijkstra RJB, van der Mei HC, Busscher HJ Walencka E, Różalska S, Sadowska B, Różalska B (2008) The
(2006) Influence of biosurfactant on interactive forces between influence of Lactobacillus acidophilus derived surfactants on
mutans streptococci and enamel measured by atomic force staphylococcal adhesion and biofilm formation. Folia Microbiol
microscopy. J Dent Res 85:54–58 53:61–66
Varnier AL, Sanchez L, Vatsa P, Boudesocque L, Garcia-Brugger A, Wang SL, Mulligan CN (2009) Arsenic mobilization from mine
Rabenoelina F, Sorokin A, Renault JH, Kauffmann S, Pugin A, tailings in the presence of a biosurfactant. Appl Geochem
Clement C, Baillieul F, Dorey S (2009) Bacterial rhamnolipids 24:928–935
are novel MAMPs conferring resistance to Botrytis cinerea in Wang Q, Fang X, Bai B, Liang X, Shuler PJ, Goddard WA III, Tang Y
grapevine. Plant Cell Environ 32:178–193 (2007) Engineering bacteria for production of rhamnolipid as an
Vater J, Kablitz B, Wilde C, Frank P, Mehta N, Cameotra SS (2002) agent for enhanced oil recovery. Biotechnol Bioeng 98:842–
Matrix-assisted laser desorption ionization time of flight mass 853
spectrometry of lipopeptide biosurin whole cells and culture Wang J, Ma T, Zhao L, Lv J, Li G, Zhang H, Zhao B, Liang F, Liu R
filtrates of Bacillus subtilis C-1 isolated from petroleum sludge. (2008) Monitoring exogenous and indigenous bacteria by PCR-
Appl Environ Microbiol 68:6210–6219 DGGE technology during the process of microbial enhanced oil
Velmurugan N, Choi MS, Han SS, Lee YS (2009) Evaluation of recovery. J Ind Microbiol Biotechnol 35:619–628
antagonistic activities of Bacillus subtilis and Bacillus lichen- Wen J, Stacey SP, McLaughlin MJ, Kirby JK (2009) Biodegradation
iformis against wood-staining fungi: in vitro and in vivo experi- of rhamnolipid, EDTA and citric acid in cadmium and zinc
ments. J Microbiol 47:385–392 contaminated soils. Soil Biol Biochem 41:2214–2221
Velraeds MCM, van der Mei HC, Reid G, Busscher HJ (1996) Xu T, Chen C, Liu C, Zhang S, Wu Y, Zhang P (2009) A novel way to
Physicochemical and biochemical characterization of biosurfac- enhance the oil recovery ratio by Streptococcus sp. BT-003. J
tants released by Lactobacillus strains. Colloids Surf B 8:51–61 Basic Microbiol 49:477–481
Velraeds MM, van de Belt-Gritter B, Busscher HJ, Reid G, Van der Yakimov MM, Timmis KN, Wray V, Fredrickson HL (1995)
Mei HC (2000) Inhibition of uropathogenic biofilm growth on Characterization of a new lipopeptide surfactant produced by
silicone rubber in human urine by lactobacilli—a teleologic thermotolerant and halotolerant subsurface Bacillus licheniformis
approach. World J Urol 18:422–426 BAS 50. Appl Environ Microbiol 61:1706–1713
Vinh DC, Embil JM (2005) Device-related infections: a review. J Zaragoza A, Aranda FJ, Espuny MJ, Teruel JA, Marqués A, Manresa
Long Term Eff Med Implants 15:467–488 Á, Ortiz A (2009) A mechanism of membrane permeabilization
Volkering F, Breure AM, Rulkens WH (1998) Microbiological aspects by a bacterial trehalose lipid biosurfactant produced by Rhodo-
of surfactant use for biological soil remediation. Biodegradation coccus sp. Langmuir 25:7892–7898
8:401–417 Zheng YG, Chen XL, Shen YC (2008) Commodity chemicals derived
Vollenbroich D, Ozel M, Vater J, Kamp RM, Pauli G (1997) from glycerol, an important biorefinery feedstock. Chem Rev
Mechanism of inactivation of enveloped viruses by the bio- 108:5253–5277
surfactant surfactin from Bacillus subtilis. Biologicals 25:289–297 Zhong H, Zeng GM, Yuan XZ, Fu HY, Huang GH, Ren FY (2007)
von Eiff C, Kohnen W, Becker K, Jansen B (2005) Modern strategies Adsorption of dirhamnolipid on four microorganisms and the
in the prevention of implant-associated infections. Int J Artif effect on cell surface hydrophobicity. Appl Microbiol Biot
Organs 28:1146–1156 77:447–455